We are happy to announce that from today.
we are adding new panel for Multiple Myeloma.
which includes conventional cytogenetics and following FISH probes:
1) del(13q14)
2) del(17p13)- p53
3) t(4;14)- FGFR3/IGH
4) t(6;14)- IRF4/IGH
5) t(11;14)- CCND1/IGH
6) t(14;16)- IGH/MAF
1/1/2012
FISH EML4-ALK
EML4-ALK FISH test available for NSCLC for crizotinib therapy.
Targeted therapies aimed at inhibiting oncogenic tyrosine
kinases are becoming commonplace in the treatment of cancer. The
EML4-ALK fusion gene was first identified as a potentially targetable
oncogenic driver in non–small cell lung cancer in 2007. A small molecule
ALK inhibitor, crizotinib, may now be on the verge of approval
by the US Food and Drug Administration for the treatment of ALKrearranged
lung cancer.
7/22/2011
mFISH
We have introduced Multicolor Fluorescence In Situ Hybridization (M-FISH)
For more details about this test, please click on "Genetic activities" - "M-FISH"
